Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration

Gu Hyun Kang, Bing Chun Yan, Geum Sil Cho, Won-Ki Kim, Choong Hyun Lee, Jun Hwi Cho, Missok Kim, Il Jun Kang, Moo Ho Won, Jae Chul Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In our previous study, we reported that lipopolysaccharide (LPS) activated microglia and accelerated cerebral ischemic injury in the rat brain through the overexpression of cytokines in microglia. In the present study, we investigated the effect of the intraperitoneal administration of fucoidin, a potent inhibitor of leukocyte rolling and anti-inflammatory agent, against accelerated cerebral ischemic injury by LPS pretreatment using rats. We found that fucoidin treatment inhibited the expressions of some brain cytokine or chemokine mRNA such as IL-8, TNF-α and iNOS in the brain of the rats treated only with LPS. We also observed that fucoidin treatment dramatically decreased the infarct size in accelerated cerebral ischemic injury induced by LPS treatment at an early time after ischemic injury. In addition, the immunoreactivity of myleoperoxidase (MPO), a marker for quantifying neutrophil accumulation, was distinctively decreased in the ischemic brain of the fucoidin-treated rat. In brief, our results indicate that fucoidin showed a neuroprotective effect on LPS accelerated cerebral ischemic injury through inhibiting the expression of some cytokine/chemokine and neutrophil recruitments.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalJournal of the Neurological Sciences
Volume318
Issue number1-2
DOIs
Publication statusPublished - 2012 Jul 15

Fingerprint

Neutrophil Infiltration
Neuroprotective Agents
Lipopolysaccharides
Cytokines
Wounds and Injuries
Brain
Microglia
Chemokines
Leukocyte Rolling
Interleukin-8
Neutrophils
Anti-Inflammatory Agents
Therapeutics
fucoidan
Messenger RNA

Keywords

  • Corpus callosum
  • Cytokines/chemokines
  • Neuroprotection
  • Neutrophil recruitment
  • Sulfated polysaccharide

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration. / Kang, Gu Hyun; Yan, Bing Chun; Cho, Geum Sil; Kim, Won-Ki; Lee, Choong Hyun; Cho, Jun Hwi; Kim, Missok; Kang, Il Jun; Won, Moo Ho; Lee, Jae Chul.

In: Journal of the Neurological Sciences, Vol. 318, No. 1-2, 15.07.2012, p. 25-30.

Research output: Contribution to journalArticle

Kang, Gu Hyun ; Yan, Bing Chun ; Cho, Geum Sil ; Kim, Won-Ki ; Lee, Choong Hyun ; Cho, Jun Hwi ; Kim, Missok ; Kang, Il Jun ; Won, Moo Ho ; Lee, Jae Chul. / Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration. In: Journal of the Neurological Sciences. 2012 ; Vol. 318, No. 1-2. pp. 25-30.
@article{e22ae7708d6a48f8a63b2e05c59bc06c,
title = "Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration",
abstract = "In our previous study, we reported that lipopolysaccharide (LPS) activated microglia and accelerated cerebral ischemic injury in the rat brain through the overexpression of cytokines in microglia. In the present study, we investigated the effect of the intraperitoneal administration of fucoidin, a potent inhibitor of leukocyte rolling and anti-inflammatory agent, against accelerated cerebral ischemic injury by LPS pretreatment using rats. We found that fucoidin treatment inhibited the expressions of some brain cytokine or chemokine mRNA such as IL-8, TNF-α and iNOS in the brain of the rats treated only with LPS. We also observed that fucoidin treatment dramatically decreased the infarct size in accelerated cerebral ischemic injury induced by LPS treatment at an early time after ischemic injury. In addition, the immunoreactivity of myleoperoxidase (MPO), a marker for quantifying neutrophil accumulation, was distinctively decreased in the ischemic brain of the fucoidin-treated rat. In brief, our results indicate that fucoidin showed a neuroprotective effect on LPS accelerated cerebral ischemic injury through inhibiting the expression of some cytokine/chemokine and neutrophil recruitments.",
keywords = "Corpus callosum, Cytokines/chemokines, Neuroprotection, Neutrophil recruitment, Sulfated polysaccharide",
author = "Kang, {Gu Hyun} and Yan, {Bing Chun} and Cho, {Geum Sil} and Won-Ki Kim and Lee, {Choong Hyun} and Cho, {Jun Hwi} and Missok Kim and Kang, {Il Jun} and Won, {Moo Ho} and Lee, {Jae Chul}",
year = "2012",
month = "7",
day = "15",
doi = "10.1016/j.jns.2012.04.013",
language = "English",
volume = "318",
pages = "25--30",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration

AU - Kang, Gu Hyun

AU - Yan, Bing Chun

AU - Cho, Geum Sil

AU - Kim, Won-Ki

AU - Lee, Choong Hyun

AU - Cho, Jun Hwi

AU - Kim, Missok

AU - Kang, Il Jun

AU - Won, Moo Ho

AU - Lee, Jae Chul

PY - 2012/7/15

Y1 - 2012/7/15

N2 - In our previous study, we reported that lipopolysaccharide (LPS) activated microglia and accelerated cerebral ischemic injury in the rat brain through the overexpression of cytokines in microglia. In the present study, we investigated the effect of the intraperitoneal administration of fucoidin, a potent inhibitor of leukocyte rolling and anti-inflammatory agent, against accelerated cerebral ischemic injury by LPS pretreatment using rats. We found that fucoidin treatment inhibited the expressions of some brain cytokine or chemokine mRNA such as IL-8, TNF-α and iNOS in the brain of the rats treated only with LPS. We also observed that fucoidin treatment dramatically decreased the infarct size in accelerated cerebral ischemic injury induced by LPS treatment at an early time after ischemic injury. In addition, the immunoreactivity of myleoperoxidase (MPO), a marker for quantifying neutrophil accumulation, was distinctively decreased in the ischemic brain of the fucoidin-treated rat. In brief, our results indicate that fucoidin showed a neuroprotective effect on LPS accelerated cerebral ischemic injury through inhibiting the expression of some cytokine/chemokine and neutrophil recruitments.

AB - In our previous study, we reported that lipopolysaccharide (LPS) activated microglia and accelerated cerebral ischemic injury in the rat brain through the overexpression of cytokines in microglia. In the present study, we investigated the effect of the intraperitoneal administration of fucoidin, a potent inhibitor of leukocyte rolling and anti-inflammatory agent, against accelerated cerebral ischemic injury by LPS pretreatment using rats. We found that fucoidin treatment inhibited the expressions of some brain cytokine or chemokine mRNA such as IL-8, TNF-α and iNOS in the brain of the rats treated only with LPS. We also observed that fucoidin treatment dramatically decreased the infarct size in accelerated cerebral ischemic injury induced by LPS treatment at an early time after ischemic injury. In addition, the immunoreactivity of myleoperoxidase (MPO), a marker for quantifying neutrophil accumulation, was distinctively decreased in the ischemic brain of the fucoidin-treated rat. In brief, our results indicate that fucoidin showed a neuroprotective effect on LPS accelerated cerebral ischemic injury through inhibiting the expression of some cytokine/chemokine and neutrophil recruitments.

KW - Corpus callosum

KW - Cytokines/chemokines

KW - Neuroprotection

KW - Neutrophil recruitment

KW - Sulfated polysaccharide

UR - http://www.scopus.com/inward/record.url?scp=84861583437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861583437&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2012.04.013

DO - 10.1016/j.jns.2012.04.013

M3 - Article

VL - 318

SP - 25

EP - 30

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -